title: Visceral leishmaniasis following treatment with liposomal amphotericin B.
authors.forename: M
authors.initials: M
authors.lastname: McBride
authors.forename: M
authors.initials: M
authors.lastname: Linney
authors.forename: E J
authors.initials: EJ
authors.lastname: Claydon
authors.forename: J
authors.initials: J
authors.lastname: Weber
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000818:Animals; D004337:Drug Carriers; D006801:Humans; D018314:Leishmania infantum / Q000187:drug effects; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000469:parasitology; D008081:Liposomes; D008297:Male; D012008:Recurrence
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B